Accessibility Menu
Phibro Animal Health logo

Phibro Animal Health

(NASDAQ) PAHC

Current Price$31.75
Market Cap$1.29B
Since IPO (2014)+137%
5 Year+26%
1 Year+28%
1 Month-3%

Phibro Animal Health Financials at a Glance

Market Cap

$1.29B

Revenue (TTM)

$1.50B

Net Income (TTM)

$95.23M

EPS (TTM)

$2.33

P/E Ratio

13.67

Dividend

$0.48

Beta (Volatility)

0.92 (Low)

Price

$31.75

Volume

537,204.11

Open

$31.79

Previous Close

$31.69

Daily Range

$31.22 - $32.31

52-Week Range

$24.96 - $60.08

Estimated Earnings Date

Aug 26, 2026

PAHC: Motley Fool Moneyball Superscore

68

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Phibro Animal Health

Industry

Pharmaceuticals

Employees

2,475

CEO

Jack C. Bendheim

Headquarters

Teaneck, NJ 07666-6712, US

PAHC Financials

Key Financial Metrics (TTM)

Gross Margin

32.49%

Operating Margin

12.27%

Net Income Margin

6.35%

Return on Equity

29.49%

Return on Capital

10.55%

Return on Assets

6.59%

Earnings Yield

7.32%

Dividend Yield

1.51%

Payout Ratio

20.43%

Stock Overview

Market Cap

$1.29B

Shares Outstanding

40.56M

Volume

537.20K

Avg. Volume

352.86K

Financials (TTM)

Gross Profit

$487.32M

Operating Income

$184.00M

EBITDA

$225.31M

Operating Cash Flow

$66.13M

Capital Expenditure

-$53.36M

Free Cash Flow

$12.77M

Cash & ST Invst.

$77.45M

Total Debt

$787.44M

Phibro Animal Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$383.54M

+10.3%

Gross Profit

$124.87M

+19.4%

Gross Margin

32.56%

N/A

Market Cap

$1.29B

N/A

Market Cap/Employee

$665.55K

N/A

Employees

1,940

N/A

Net Income

$24.02M

+15.1%

EBITDA

$55.64M

+8.3%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$77.45M

+10.1%

Total Debt

$787.44M

+2.3%

Accounts Receivable

$221.55M

+12.2%

Inventory

$539.70M

+20.4%

Long Term Debt

$755.19M

+1.4%

Short Term Debt

$32.25M

+27.8%

Return on Assets

6.59%

N/A

Return on Invested Capital

15.82%

N/A

Free Cash Flow

$890.00K

-97.5%

Operating Cash Flow

$16.21M

-62.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MNKDMannKind Corporation
$4.14+5.34%
ALVOAlvotech
$3.68+5.75%
EVOEvotec SE
$2.74+1.11%
ANIPANI Pharmaceuticals, Inc.
$84.50+1.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.87+0.02%
SPCXSpace Exploration Technologies
$153.23+0.00%
ONDSOndas
$7.83+0.02%
KEELKeel Infrastructure
$6.03+0.03%

Questions About PAHC

What is the current price of Phibro Animal Health?

Phibro Animal Health is trading at $31.69 per share.

What is the 52-week range for Phibro Animal Health?

Over the past 52 weeks, Phibro Animal Health has traded between $24.96 and $60.08.

How much debt does Phibro Animal Health have?

As of the most recent reporting period, Phibro Animal Health reported total debt of $787.44M.

How much cash does Phibro Animal Health have on hand?

Phibro Animal Health reported $54.93M in cash and cash equivalents in its most recent financial results.

What is Phibro Animal Health’s dividend yield?

Phibro Animal Health currently has a dividend yield of 1.51%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.